We are live on ! Find out more
BIA

Benchmark Investment Advisors Portfolio holdings

AUM $172M
This Fund
S&P 500
This Quarter Est. Return
-4.6%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$92.8M
AUM Growth
-$3.09M
Cap. Flow
+$2.78M
Cap. Flow %
2.99%
Top 10 Hldgs %
34.3%
Holding
99
New
8
Increased
29
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.57M
2
TSLA icon
Tesla
TSLA
+$1.43M
3
NVDA icon
NVIDIA
NVDA
+$960K
4
ROP icon
Roper Technologies
ROP
+$770K
5
PXD
Pioneer Natural Resource Co.
PXD
+$669K

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$784K
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$738K
3
CPB icon
Campbell Soup
CPB
+$706K
4
DIS icon
Walt Disney
DIS
+$558K
5
MRNA icon
Moderna
MRNA
+$510K

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 13.34%
3 Consumer Discretionary 9.8%
4 Financials 8.46%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICE icon
51
Intercontinental Exchange
ICE
$84.4B
$528K 0.57%
5,845
-107
-2% -$10.7K
ABBV icon
52
AbbVie
ABBV
$435B
$509K 0.55%
3,793
-1,366
-26% -$196K
AVGO icon
53
Broadcom
AVGO
$2.04T
$489K 0.53%
+11,020
New +$563K
SLV icon
54
iShares Silver Trust
SLV
$30.7B
$488K 0.53%
27,900
DIS icon
55
Walt Disney
DIS
$181B
$485K 0.52%
5,139
-5,213
-50% -$558K
QCOM icon
56
Qualcomm
QCOM
$176B
$469K 0.51%
+4,150
New +$570K
MRK icon
57
Merck
MRK
$318B
$462K 0.5%
5,370
-1,446
-21% -$129K
STX icon
58
Seagate
STX
$184B
$443K 0.48%
8,323
-197
-2% -$14.2K
ADSK icon
59
Autodesk
ADSK
$52.6B
$432K 0.47%
2,314
-20
-0.9% -$4.04K
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.77B
$429K 0.46%
3,883
+110
+3% +$11.1K
CLX icon
61
Clorox
CLX
$12.7B
$424K 0.46%
3,300
-400
-11% -$57.7K
ABNB icon
62
Airbnb
ABNB
$106B
$405K 0.44%
3,860
-25
-0.6% -$2.77K
DVYE icon
63
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$405K 0.44%
+17,872
New +$455K
O icon
64
Realty Income
O
$59.1B
$402K 0.43%
6,900
TIP icon
65
iShares TIPS Bond ETF
TIP
$14.5B
$398K 0.43%
3,793
+568
+18% +$64.3K
DOCU
66
DocuSign
DOCU
$11.5B
$391K 0.42%
7,320
-1,475
-17% -$92.5K
EOG icon
67
EOG Resources
EOG
$70.7B
$390K 0.42%
+3,487
New +$391K
GOOG icon
68
Alphabet (Google) Class C
GOOG
$4.32T
$385K 0.41%
4,000
IBM icon
69
IBM
IBM
$224B
$368K 0.4%
3,099
-918
-23% -$120K
LYB icon
70
LyondellBasell Industries
LYB
$19.2B
$363K 0.39%
4,817
-1,203
-20% -$102K
LTC
71
LTC Properties
LTC
$2.15B
$336K 0.36%
8,970
WELL icon
72
Welltower
WELL
$171B
$325K 0.35%
5,060
MDT icon
73
Medtronic
MDT
$112B
$312K 0.34%
3,869
-3,428
-47% -$308K
NVS icon
74
Novartis
NVS
$297B
$312K 0.34%
4,107
-256
-6% -$21.2K
VCSH icon
75
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$307K 0.33%
4,134
+8
+0.2% +$610

Similar funds

Benchmark Investment Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Benchmark Investment Advisors held 99 positions worth $92.8M, down 3.2% from $95.9M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Benchmark Investment Advisors's Q3 2022 filing shows 8 new, 29 increased, 43 reduced and 5 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 2,928 shares worth $634K. The largest sale was Morgan Stanley, an estimated $784K.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Benchmark Investment Advisors's largest Q3 2022 buy was Pioneer Natural Resource Co.: 2,928 shares worth $634K.
  • Benchmark Investment Advisors added most to Pfizer in Q3 2022, an estimated $1.57M increase.
  • Benchmark Investment Advisors's biggest Q3 2022 reduction was Morgan Stanley, cutting an estimated $784K.
  • Benchmark Investment Advisors fully exited Campbell Soup in Q3 2022, selling an estimated $706K.
  • Benchmark Investment Advisors's ten largest holdings make up 34% of its $92.8M portfolio in Q3 2022.
  • Benchmark Investment Advisors opened 8 new positions and closed 5 in Q3 2022.
  • Benchmark Investment Advisors's portfolio value fell 3.2% quarter-over-quarter to $92.8M.

Based on Benchmark Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.